Your physician has you come into his office and run on a treadmill while you're hooked up to an EKG. For the next 8 to 12 minutes, he'll evaluate your heart rate, breathing, and blood pressure as the intensity of the workout increases. When the stress test is over, he'll tell you whether you have coronary artery disease.
We now know that CP (Chlamydophila pneumoniae) can persist intracellularly in a cryptic and arrested state, that cannot be cultured, is immunologically muted, and becomes resistant to antibiotics.
By 2011, there was 1635 published research on CP as a mechanism of heart disease. Since nothing much can be done to treat CP that lodged inside the wall of the blood vessel the interest and new ideas to treat is not developed. However, chelation therapy has the understood mechanism to bind metal ion.
ECP therapy, A unique opportunity to save countless lives and billions of dollars is being overlooked by the medical community. This technique increases blood flow to the heart, strengthens the circulation, and offers a proven way to treat heart disease in lieu of stents or bypass surgery.
What is this technique? It is called ECP (External Counter Pulsation) FDA approved since 1987 for :
Ivor Cummins, a biochemical engineer with a background in medical device engineering and leading teams in complex problem solving.
“The Fat Emperor: Insulin Versus Cholesterol,” features Ivor Cummins in the video :
It’s been clear for some time that psychological stress is linked to high blood pressure, or hypertension. Stress-hypertension link have been conducted in laboratories, using staged activities such as public speaking and mental arithmetic to “stress out” participants.
Now, in a “real-world” setting, a research team in Italy has confirmed that mild stress can increase blood pressure and impair the cardiovascular system’s ability to regulate itself.
These changes might contribute, in susceptible individuals, to the link between psychological stress and increased cardiovascular risk of hypertension.
It has been shown that people with heart disease can lower their risk of subsequent cardiac events by over 70% if they learn how to manage stress.
EDTA Chelation Therapy Proves Highly Significant Benefits Up to 50% prevention of recurrent heart attacks and 43 percent reduction in death rate from all causes.
At the American Heart Association meeting in Los Angeles on November 4, 2012, Dr. Gervasio Lamas, principal investigator, presented results of the NIH-sponsored Trial to Assess Chelation Therapy (TACT). This randomized, placebo-controlled study of 1,708 patients showed that intravenous disodium EDTA chelation therapy decreased subsequent cardiac events with statistical significance, when compared to a control group of similar patients who received placebo.
Noradrenaline and adrenaline are catecholamines that play major roles in regulation of the ‘inner world’ of the body by the brain. Noradrenaline (synonymous with norepinephrine), the main neurotransmitter of the sympathetic nervous system, is responsible for tonic and reflexive changes in cardiovascular tone. Adrenaline is a key determinant of responses to metabolic or global challenges to homeostasis, such as glucoprivation(increases expression of neuropeptide Y mRNA in hindbrain neurons that innervate the hypothalamus) and of manifestations of emotional distress. In contrast with the view that the sympathetic nervous and adrenomedullary hormonal systems function as a unit (the ‘sympathoadrenal system’) to maintain homeostasis in emergencies, across a variety of situations, adrenaline responses are more closely linked to responses of the hypothalamic?pituitary?adrenocortical system than of the sympathetic nervous system. The sympathetic noradrenergic system is active even when the individual is at rest and maintains tonic levels of cardiovascular performance. Adrenoceptors in the membranes of effector cells determine the physiological and metabolic effects of catecholamines.
MRFIT Trial: Does high cholesterol cause heart disease?
Here’s another trial for thought:
They come up with great names for research trials. MRFIT actually means Multiple Risk Factor Intervention Trial. Done in the early 1970’s to prove that the risk factors associated with heart disease were cigarette smoking, high cholesterol, and high blood pressure.
We had seen more people who had so called heart attack (myocardial infarction) with normal cholesterol than with high cholesterol. Many of them had regular blood test and was told that their blood parameters essentially normal, including cholesterol however end-up with heart attack not long after.
Adopted here is the summary of the issue by Majid Ali. MD. Our approach following his “aa oxidoptahy” hypothesis yield good result more often than not consistent with his study that is about 90% at all time.
CRP is an inflammatory marker produce by the liver. It is more predictable than any other parameters for all chronic and degenerative disease process especially blood vessel disease with manifestation of coronary heart disease, diabetic foot gangrene and stroke. Inflammation is the core or triggering process to free radicals. There are many factors accelerate inflammation and many of the factors are over-lapping with factors that accelerate free radicals. They are the core process for aging related disorders such as coronary heart disease, stroke, cancer, osteoarthritis, macular degeneration, polyneuropathy, skin wrinkle, etc.
Blood pressure is major risk factor for heart disease, stroke, congestive heart failure, and kidney failure, it acts as an accomplice in millions of additional deaths each year.